The Effect of a Neuronal Nitric Oxide Synthase Inhibitor on Neurovascular Regulation in Humans.
neurovascular coupling
nitric oxide
Journal
Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103
Informations de publication
Date de publication:
02 12 2022
02 12 2022
Historique:
pubmed:
10
11
2022
medline:
6
12
2022
entrez:
9
11
2022
Statut:
ppublish
Résumé
Neurovascular coupling (NVC) is a key process in cerebral blood flow regulation. NVC ensures adequate brain perfusion to changes in local metabolic demands. Neuronal nitric oxide synthase (nNOS) is suspected to be involved in NVC; however, this has not been tested in humans. Our objective was to investigate the effects of nNOS inhibition on NVC in humans. We performed a 3-visit partially randomized, double-blinded, placebo-controlled, crossover study in 12 healthy subjects. On each visit, subjects received an intravenous infusion of either S-methyl-L-thiocitrulline (a selective nNOS-inhibitor), 0.9% saline (placebo control), or phenylephrine (pressor control). The NVC assessment involved eliciting posterior circulation hyperemia through visual stimulation while measuring posterior and middle cerebral arteries blood velocity. nNOS inhibition blunted the rapidity of the NVC response versus pressor control, evidenced by a reduced initial rise in mean posterior cerebral artery velocity (-3.3% [-6.5, -0.01], Neuronal NOS plays a role in dynamic cerebral blood flow control in healthy adults, particularly the rapidity of the NVC response to visual stimulation. This work opens the way to further investigation of the role of nNOS in conditions of impaired NVC, potentially revealing a therapeutic target.
Sections du résumé
BACKGROUND
Neurovascular coupling (NVC) is a key process in cerebral blood flow regulation. NVC ensures adequate brain perfusion to changes in local metabolic demands. Neuronal nitric oxide synthase (nNOS) is suspected to be involved in NVC; however, this has not been tested in humans. Our objective was to investigate the effects of nNOS inhibition on NVC in humans.
METHODS
We performed a 3-visit partially randomized, double-blinded, placebo-controlled, crossover study in 12 healthy subjects. On each visit, subjects received an intravenous infusion of either S-methyl-L-thiocitrulline (a selective nNOS-inhibitor), 0.9% saline (placebo control), or phenylephrine (pressor control). The NVC assessment involved eliciting posterior circulation hyperemia through visual stimulation while measuring posterior and middle cerebral arteries blood velocity.
RESULTS
nNOS inhibition blunted the rapidity of the NVC response versus pressor control, evidenced by a reduced initial rise in mean posterior cerebral artery velocity (-3.3% [-6.5, -0.01],
CONCLUSIONS
Neuronal NOS plays a role in dynamic cerebral blood flow control in healthy adults, particularly the rapidity of the NVC response to visual stimulation. This work opens the way to further investigation of the role of nNOS in conditions of impaired NVC, potentially revealing a therapeutic target.
Identifiants
pubmed: 36349758
doi: 10.1161/CIRCRESAHA.122.321631
pmc: PMC9770134
doi:
Substances chimiques
Enzyme Inhibitors
0
Nitric Oxide
31C4KY9ESH
Nitric Oxide Synthase Type I
EC 1.14.13.39
S-methylthiocitrulline
M790X706JV
thiocitrulline
0
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
952-961Subventions
Organisme : Medical Research Council
ID : MR/R017751/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/1999001/11735
Pays : United Kingdom
Références
Hypertension. 2017 May;69(5):970-976
pubmed: 28264923
Circulation. 2009 May 26;119(20):2656-62
pubmed: 19433760
Circulation. 1994 May;89(5):2035-40
pubmed: 7514109
J Cereb Blood Flow Metab. 2018 Mar;38(3):528-539
pubmed: 28361587
J Appl Physiol (1985). 2014 Nov 1;117(9):1037-48
pubmed: 25170067
Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H619-31
pubmed: 18502903
Circulation. 2008 Apr 15;117(15):1991-6
pubmed: 18391107
J Cereb Blood Flow Metab. 1994 Mar;14(2):175-92
pubmed: 7509338
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7593-8
pubmed: 11390971
Neuroimage. 2003 Jan;18(1):1-9
pubmed: 12507439
Nat Neurosci. 2020 Sep;23(9):1079-1089
pubmed: 32778793
Nat Rev Neurosci. 2004 May;5(5):347-60
pubmed: 15100718
Stroke. 1999 Dec;30(12):2727-34; discussion 2734
pubmed: 10583004
Nature. 2010 Nov 11;468(7321):232-43
pubmed: 21068832
J Cereb Blood Flow Metab. 2014 May;34(5):794-801
pubmed: 24473484
J Neurotrauma. 2018 Jun 15;35(12):1345-1357
pubmed: 29338544
Clin Sci (Lond). 2000 Dec;99(6):555-60
pubmed: 11099400
Nature. 2014 Apr 3;508(7494):55-60
pubmed: 24670647
Neurology. 2005 Apr 26;64(8):1358-65
pubmed: 15851723
Nature. 2004 Sep 9;431(7005):195-9
pubmed: 15356633
J Physiol. 2014 Mar 1;592(5):841-59
pubmed: 24396059
Brain Res Rev. 2007 Nov;56(1):89-100
pubmed: 17716743
J Nucl Med. 1997 Aug;38(8):1273-8
pubmed: 9255165
J Neurotrauma. 2017 Mar 15;34(6):1283-1288
pubmed: 27998205
J Physiol. 2020 Nov;598(21):4927-4939
pubmed: 32785972
J Cereb Blood Flow Metab. 2020 Aug;40(8):1647-1657
pubmed: 31426699
Circulation. 2021 Jul 27;144(4):e70-e91
pubmed: 34032474
Nat Med. 2017 Jun;23(6):733-741
pubmed: 28459438
J Biol Chem. 1994 Oct 28;269(43):26677-83
pubmed: 7523410
Am J Physiol. 1994 Dec;267(6 Pt 2):H2155-62
pubmed: 7528990
J Cereb Blood Flow Metab. 2020 Mar;40(3):656-666
pubmed: 30841780
Stroke. 1998 Feb;29(2):467-72
pubmed: 9472891
J Neurotrauma. 2019 May 1;36(9):1487-1490
pubmed: 30458117
Physiol Behav. 2021 Feb 1;229:113198
pubmed: 33068563
Cardiovasc Res. 2022 Mar 25;118(5):1321-1329
pubmed: 34120160
Circ Res. 2019 Mar 29;124(7):1025-1044
pubmed: 30920929
Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H821-9
pubmed: 11158982
J Appl Physiol (1985). 2014 Mar 15;116(6):645-53
pubmed: 24436297
Neurosci Biobehav Rev. 2019 Jan;96:174-181
pubmed: 30481531
Radiographics. 1995 Jan;15(1):179-91
pubmed: 7899596
Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H863-9
pubmed: 15008160